Cargando…

Increased Clot Formation in the Absence of Increased Thrombin Generation in Patients with Peripheral Arterial Disease: A Case–Control Study

BACKGROUND: In peripheral arterial disease (PAD), activation of the hemostatic system may contribute to atherosclerosis progression and atherothrombotic events. OBJECTIVE: This case–control study assesses the overall coagulation status in PAD patients by evaluating coagulation markers in combination...

Descripción completa

Detalles Bibliográficos
Autores principales: Kleinegris, Marie-Claire F., Konings, Joke, Daemen, Jan W., Henskens, Yvonne, de Laat, Bas, Spronk, Henri M. H., ten Cate-Hoek, Arina J., ten Cate, Hugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397513/
https://www.ncbi.nlm.nih.gov/pubmed/28473975
http://dx.doi.org/10.3389/fcvm.2017.00023
_version_ 1783230271724716032
author Kleinegris, Marie-Claire F.
Konings, Joke
Daemen, Jan W.
Henskens, Yvonne
de Laat, Bas
Spronk, Henri M. H.
ten Cate-Hoek, Arina J.
ten Cate, Hugo
author_facet Kleinegris, Marie-Claire F.
Konings, Joke
Daemen, Jan W.
Henskens, Yvonne
de Laat, Bas
Spronk, Henri M. H.
ten Cate-Hoek, Arina J.
ten Cate, Hugo
author_sort Kleinegris, Marie-Claire F.
collection PubMed
description BACKGROUND: In peripheral arterial disease (PAD), activation of the hemostatic system may contribute to atherosclerosis progression and atherothrombotic events. OBJECTIVE: This case–control study assesses the overall coagulation status in PAD patients by evaluating coagulation markers in combination with thrombin generation potential, whole blood (WB) clot formation, and fibrinolysis. METHODS: In blood from 40 PAD patients (n = 20 with cardiovascular event within 1 year after initial diagnosis, n = 20 without) and 40 apparently healthy controls, thrombin generation was determined in WB and platelet-poor plasma. Whole blood rotational thromboelastometry (ROTEM) measurements were triggered with tissue factor with/without tissue plasminogen activator. RESULTS: We observed increased levels of erythrocyte sedimentation rate, leukocytes, eosinophil granulocytes, vWF antigen, fibrinogen, and D-dimer in PAD patients (p < 0.05). Markers of thrombin generation potential showed no difference between patients and healthy controls. In PAD patients with event compared to patients without, WB-thrombin generation showed a lower thrombin potential when triggered with 0 and 2.5 pM tissue factor. The ROTEM clotting assay showed significantly faster clot formation and increased clot firmness in PAD patients compared to controls. No significant differences were found for parameters of clot degradation. CONCLUSION: There are no significant differences between the thrombin generation profiles of PAD patients and healthy controls. Between PAD patients with and without cardiovascular event, the WB thrombin generation appears to differ. Mechanistically, PAD patients show an increased ability to form a stable clot in WB in comparison to healthy controls. This is most likely due to the increased fibrinogen levels related to the inflammation in atherosclerosis, confirming the importance of the inflammation-coagulation axis.
format Online
Article
Text
id pubmed-5397513
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-53975132017-05-04 Increased Clot Formation in the Absence of Increased Thrombin Generation in Patients with Peripheral Arterial Disease: A Case–Control Study Kleinegris, Marie-Claire F. Konings, Joke Daemen, Jan W. Henskens, Yvonne de Laat, Bas Spronk, Henri M. H. ten Cate-Hoek, Arina J. ten Cate, Hugo Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: In peripheral arterial disease (PAD), activation of the hemostatic system may contribute to atherosclerosis progression and atherothrombotic events. OBJECTIVE: This case–control study assesses the overall coagulation status in PAD patients by evaluating coagulation markers in combination with thrombin generation potential, whole blood (WB) clot formation, and fibrinolysis. METHODS: In blood from 40 PAD patients (n = 20 with cardiovascular event within 1 year after initial diagnosis, n = 20 without) and 40 apparently healthy controls, thrombin generation was determined in WB and platelet-poor plasma. Whole blood rotational thromboelastometry (ROTEM) measurements were triggered with tissue factor with/without tissue plasminogen activator. RESULTS: We observed increased levels of erythrocyte sedimentation rate, leukocytes, eosinophil granulocytes, vWF antigen, fibrinogen, and D-dimer in PAD patients (p < 0.05). Markers of thrombin generation potential showed no difference between patients and healthy controls. In PAD patients with event compared to patients without, WB-thrombin generation showed a lower thrombin potential when triggered with 0 and 2.5 pM tissue factor. The ROTEM clotting assay showed significantly faster clot formation and increased clot firmness in PAD patients compared to controls. No significant differences were found for parameters of clot degradation. CONCLUSION: There are no significant differences between the thrombin generation profiles of PAD patients and healthy controls. Between PAD patients with and without cardiovascular event, the WB thrombin generation appears to differ. Mechanistically, PAD patients show an increased ability to form a stable clot in WB in comparison to healthy controls. This is most likely due to the increased fibrinogen levels related to the inflammation in atherosclerosis, confirming the importance of the inflammation-coagulation axis. Frontiers Media S.A. 2017-04-20 /pmc/articles/PMC5397513/ /pubmed/28473975 http://dx.doi.org/10.3389/fcvm.2017.00023 Text en Copyright © 2017 Kleinegris, Konings, Daemen, Henskens, de Laat, Spronk, ten Cate-Hoek and ten Cate. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Kleinegris, Marie-Claire F.
Konings, Joke
Daemen, Jan W.
Henskens, Yvonne
de Laat, Bas
Spronk, Henri M. H.
ten Cate-Hoek, Arina J.
ten Cate, Hugo
Increased Clot Formation in the Absence of Increased Thrombin Generation in Patients with Peripheral Arterial Disease: A Case–Control Study
title Increased Clot Formation in the Absence of Increased Thrombin Generation in Patients with Peripheral Arterial Disease: A Case–Control Study
title_full Increased Clot Formation in the Absence of Increased Thrombin Generation in Patients with Peripheral Arterial Disease: A Case–Control Study
title_fullStr Increased Clot Formation in the Absence of Increased Thrombin Generation in Patients with Peripheral Arterial Disease: A Case–Control Study
title_full_unstemmed Increased Clot Formation in the Absence of Increased Thrombin Generation in Patients with Peripheral Arterial Disease: A Case–Control Study
title_short Increased Clot Formation in the Absence of Increased Thrombin Generation in Patients with Peripheral Arterial Disease: A Case–Control Study
title_sort increased clot formation in the absence of increased thrombin generation in patients with peripheral arterial disease: a case–control study
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397513/
https://www.ncbi.nlm.nih.gov/pubmed/28473975
http://dx.doi.org/10.3389/fcvm.2017.00023
work_keys_str_mv AT kleinegrismarieclairef increasedclotformationintheabsenceofincreasedthrombingenerationinpatientswithperipheralarterialdiseaseacasecontrolstudy
AT koningsjoke increasedclotformationintheabsenceofincreasedthrombingenerationinpatientswithperipheralarterialdiseaseacasecontrolstudy
AT daemenjanw increasedclotformationintheabsenceofincreasedthrombingenerationinpatientswithperipheralarterialdiseaseacasecontrolstudy
AT henskensyvonne increasedclotformationintheabsenceofincreasedthrombingenerationinpatientswithperipheralarterialdiseaseacasecontrolstudy
AT delaatbas increasedclotformationintheabsenceofincreasedthrombingenerationinpatientswithperipheralarterialdiseaseacasecontrolstudy
AT spronkhenrimh increasedclotformationintheabsenceofincreasedthrombingenerationinpatientswithperipheralarterialdiseaseacasecontrolstudy
AT tencatehoekarinaj increasedclotformationintheabsenceofincreasedthrombingenerationinpatientswithperipheralarterialdiseaseacasecontrolstudy
AT tencatehugo increasedclotformationintheabsenceofincreasedthrombingenerationinpatientswithperipheralarterialdiseaseacasecontrolstudy